All Stories

  1. Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatment
  2. Impact of clinically diagnosed liver cirrhosis in patients with intrahepatic cholangiocarcinoma treated with systemic chemotherapy: a subgroup analysis of JCOG1113
  3. Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting
  4. Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113
  5. Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting
  6. Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021–22
  7. Development of a nomogram to predict survival in advanced biliary tract cancer
  8. Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment
  9. Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis
  10. Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreas
  11. Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study
  12. Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: A retrospective multicenter cohort study
  13. Clinical Outcomes of Chemotherapy in Patients with Undifferentiated Carcinoma of the Pancreas: A Retrospective Multicenter Cohort Study
  14. Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study
  15. Impact of the Duration of Diabetes Mellitus on the Outcome of Metastatic Pancreatic Cancer Treated with Gemcitabine: A Retrospective Study
  16. New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer
  17. Safety and efficacy of endoscopic ultrasound‐guided fine needle aspiration for pancreatic masses: A prospective multicenter study
  18. EUS-guided n-butyl-2-cyanoacrylate injection therapy for ruptured isolated left gastric artery pseudoaneurysm
  19. Endoscopic Ultrasound-Guided Gallbladder Drainage for Aberrant Right Posterior Duct Obstruction Developing after Placement of a Covered Self-Expandable Metallic Stent in a Patient with Distal Biliary Obstruction
  20. Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study
  21. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
  22. Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors
  23. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy
  24. Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma
  25. Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms
  26. Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer
  27. The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome
  28. Treatment of biliary strictures with fully covered self-expandable metal stents after pancreaticoduodenectomy
  29. Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients
  30. Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: A retrospective cohort study
  31. Benefits of side‐by‐side deployment of 6‐mm covered self‐expandable metal stents for hilar malignant biliary obstructions
  32. Post-adjuvant chemotherapy CA19-9 levels predict prognosis in patients with pancreatic ductal adenocarcinoma: A retrospective cohort study
  33. Clinical outcome of elderly patients with unresectable pancreatic cancer treated with gemcitabine plus S-1, S-1 alone, or gemcitabine alone: Subgroup analysis of a randomised phase III trial, GEST study.
  34. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer
  35. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms
  36. Clinical impact of preoperative endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma
  37. Endoscopic ultrasonography-guided biliary drainage: Who, when, which, and how?
  38. Type of Combined Endoscopic Biliary and Gastroduodenal Stenting Is Significant for Biliary Route Maintenance
  39. Comparison of the clinical impact of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for bile duct obstruction with duodenal obstruction
  40. Comparison of the clinical impact of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for bile duct obstruction with duodenal obstruction
  41. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long‐term follow‐up study: proposals for follow‐up strategies
  42. Stent migration into the peritoneal cavity following endoscopic ultrasound-guided hepaticogastrostomy
  43. Morphological differentiation and follow-up of pancreatic cystic neoplasms using endoscopic ultrasound
  44. A Randomized Controlled Trial Evaluating a Low-Volume PEG Solution Plus Ascorbic Acid versus Standard PEG Solution in Bowel Preparation for Colonoscopy
  45. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms
  46. Clinical course of gastrointestinal stromal tumor diagnosed by endoscopic ultrasound-guided fine-needle aspiration
  47. Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
  48. A novel technique for endoscopic transpapillary “mapping biopsy specimens” of superficial intraductal spread of bile duct carcinoma (with videos)
  49. Ring-enhancement pattern on contrast-enhanced CT predicts adenosquamous carcinoma of the pancreas: A matched case-control study
  50. Gastroduodenal stenting with Niti‐S stent: Long‐term benefits and additional stent intervention
  51. Can Long-Term Follow-Up Strategies Be Determined Using a Nomogram-Based Prediction Model of Malignancy Among Intraductal Papillary Mucinous Neoplasms of the Pancreas?
  52. Clinical Characteristics of Adenosquamous Carcinoma of the Pancreas
  53. Endoscopic ultrasound description of liver segmentation and anatomy
  54. Evaluation of Ki-67 index in EUS–FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors
  55. Risk of second malignancies in patients with gastric marginal zone lymphomas of mucosa associate lymphoid tissue (MALT)
  56. Prospective clinical study of endoscopic ultrasound-guided choledochoduodenostomy with direct metallic stent placement using a forward-viewing echoendoscope
  57. Can mosapride citrate reduce the volume of lavage solution for colonoscopy preparation?
  58. Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma
  59. Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience
  60. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
  61. A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1
  62. Endoscopic Ultrasound-Guided Choledochoduodenostomy for Malignant Lower Biliary Tract Obstruction
  63. Can Endoscopic Ultrasound-Guided Fine Needle Aspiration Offer Clinical Benefit for Tumors of the Ampulla of Vater? -An Initial Study
  64. Pseudomyxoma peritonei arising from intraductal papillary neoplasm after surgical pancreatectomy: report of 2 cases and review of the literature
  65. Diagnostic yield of endoscopic retrograde cholangiography and of EUS‐guided fine needle aspiration sampling in gallbladder carcinomas
  66. Comparison of endoscopic submucosal dissection and endoscopic mucosal resection for large colorectal tumors
  67. Fibroblast-derived HB-EGF promotes Cdx2 expression in esophageal squamous cells
  68. Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice
  69. In vivo evidence for the role of RegI in gastric regeneration: transgenic overexpression of RegI accelerates the healing of experimental gastric ulcers
  70. Is Autofluorescence Imaging Endoscopy Useful for Determining the Depth of Invasion in Gastric Cancer
  71. Rare pancreatic neoplasms: the utility of endoscopic ultrasound-guided fine-needle aspiration—a large single center study
  72. Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?
  73. Endoscopic Ultrasound-Guided Fine-Needle Aspiration of a Mixed Acinar-Endocrine Carcinoma: A Case Report
  74. API2‐MALT1 chimeric transcript‐positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years
  75. EUS-guided choledochoduodenostomy for palliative biliary drainage in case of papillary obstruction: report of 2 cases
  76. A Japanese case of eosinophilic esophagitis
  77. Pseudomyxoma Peritonei Caused by Acute Pancreatitis in Intraductal Papillary Mucinous Carcinoma of the Pancreas
  78. LONG‐TERM FOLLOW UP OF PATIENTS WITH SMALL GASTROINTESTINAL STROMAL TUMORS IN THE STOMACH USING ENDOSCOPIC ULTRASONOGRAPHY‐GUIDED FINE‐NEEDLE ASPIRATION BIOPSY
  79. Pancreatic Endocrine Neoplasm Can Mimic Serous Cystadenoma
  80. Endoscopic ultrasonography‐guided fine‐needle aspiration biopsy: A safe method for accurate diagnosis